Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2018/0044451 PVOH DISPERSANT FOR VCM POLYMERIZATION
Dispersing agents useful in a suspension polymerization process may be formed based on polyvinyl alcohols and processes discloses herein. The dispersing agent...
2018/0044450 BRIDGED METALLOCENE COMPLEX FOR OLEFIN POLYMERIZATION
The invention relates to a metallocene complex according to formula (1) wherein M is a metal selected from lanthanides or transition metals from group 3, 4, 5...
2018/0044449 POLYMERS DERIVED FROM NORBORNADIENE AND MALEIC ANHYDRIDE AND USE THEREOF
Embodiments encompassing a series of compositions containing polymers of norbornadiene and maleic anhydride monomers which are useful in forming a variety of...
2018/0044448 ADDITION-FRAGMENTATION OLIGOMERS
Novel stress-reducing crosslinking oligomers that have application in dental restoratives, thin films, hardcoats, composites, adhesives, and other uses subject...
2018/0044447 METHOD FOR THE PREPARATION OF NITRATED STYRENIC FLUOROPOLYMERS
Disclosed is a process for making nitrated styrenic fluoropolymers having various degrees of substitution. The nitrated styrenic fluoropolymer is capable of...
2018/0044446 Process for Reducing the Light Oligomer Content of Polypropylene Oils
Disclosed herein are dual catalyst compositions containing an unbridged metallocene compound, a bridged metallocene compound, a chemically-treated solid oxide,...
2018/0044445 SYSTEMS AND METHODS RELATED TO THE PRODUCTION OF POLYETHYLENE
Disclosed herein is a method comprising the steps of: a) producing a hydrocarbon stream from syngas via a Fischer-Tropsch reaction, wherein the hydrocarbon...
2018/0044444 OPTICAL COMPENSATION FILMS BASED ON STYRENIC FLUOROPOLYMER
Disclosed are optical compensation films with exceptionally high positive out-of-plane birefringence. The optical compensation films are based on substituted...
2018/0044443 EFFICIENT COPOLYMERS HAVING AN AGGLOMERATING EFFECT
The invention relates to graft copolymers (B) composed of an agglomerated graft core (B1) and at least one graft shell (B2) and also to copolymers (C) having...
2018/0044442 METHOD FOR PRODUCTION OF HEPARIN AND HEPARAN SULFATE
This present disclosure relates to a method of producing a proteoglycan having anticoagulant activity, comprising of and providing a cell transfected with a...
2018/0044441 Chondroitin sulfate preparation process and equipment thereof
A chondroitin sulfate preparation process and device thereof and in particular a process for extracting ten thousand tons of chondroitin sulfate by means of a...
2018/0044440 BETA-1,3-GLUCAN DERIVATIVE AND METHOD FOR PRODUCING BETA-1,3-GLUCAN DERIVATIVE
An object of the present invention is to provide a .beta.-1,3-glucan derivative which is a polymer having .beta.-1,3-glucan as a main chain, and has...
2018/0044439 CELLULOSE SUSPENSION, METHOD FOR THE PRODUCTION AND USE THEREOF
The present invention relates to a phase-stable suspension of cellulose II in water, having a high water retention capacity and a cellulose concentration...
2018/0044438 METHOD FOR PROCESSING CELLULOSE-CONTAINING BIOMASS
Described is a method for processing cellulose-containing biomass with sulfuric acid and certain additives, especially for the pretreatment of ...
2018/0044437 Anti-inflammatory molecules with tissue-targeting functions
The present disclosure provides various molecular constructs having a targeting element and an effector element. Methods for treating osteoporosis using such...
2018/0044436 Stabilized Formulations Containing Anti-PCSK9 Antibodies
The present invention provides pharmaceutical formulations comprising a human antibody that specifically binds to human proprotein convertase subtilisin/kexin...
2018/0044435 ANTI-HUMAN MEMBRANE-TYPE ADAM28 ANTIBODY
The present invention provides an antibody having an activity to specifically bind to human membrane-anchored form ADAM28 at an epitope in a region of the...
2018/0044434 NOVEL ANTI-PAD4 ANTIBODY
Provided are anti-PAD4 antibodies having excellent properties and an excellent method for treatment of RA. Used are anti-PAD4 antibodies that specifically bind...
2018/0044433 COMPOUNDS BINDING TO JMJD6 WITH ANTIFIBROTIC ACTIVITY
The present invention relates to the interaction between JMJD6 protein and collagen and to the possibility of inhibiting this interaction for the prevention...
2018/0044432 TREATMENT OF OCULAR DISEASE
Disclosed are methods for treating eye diseases or conditions characterized by vascular instability, vascular leakage and neovacularization such as diabetic...
2018/0044431 HUMAN ANTIBODIES AGAINST TISSUE FACTOR AND METHODS OF USE THEREOF
Isolated human monoclonal antibodies which bind to human TF and related antibody-based compositions and molecules, are disclosed. Also disclosed are...
2018/0044430 FC Engineered Anti-TNFR Superfamily Member Antibodies Having Enhanced Atonistic Activity and Methods of Using Them
The present invention relates to engineered anti-TNFR superfamily member antibodies having enhanced agonistic activity and methods of using them.
2018/0044429 CD27 AGONISTS
The invention provides CD27 agonists comprising a first component that is an anti-CD27 antibody, or antigen-binding fragment thereof, linked to a second...
2018/0044428 COMPOSITIONS AND METHODS FOR ENHANCING THE EFFICACY OF CANCER THERAPY
The present invention features compositions and methods for enhancing an anti-tumor response by administering an OX40 agonist (e.g., an anti-OX40 antibody)...
2018/0044427 Engineered Antibodies and Other FC-Domain Containing Molecules with Enhanced Agonism and Effector Functions
The present invention relates to engineered antibodies and other Fc-domain containing molecules with enhanced agonism and effector functions.
2018/0044426 USE OF IL-31RA MONOCLONAL ANTIBODIES FOR ANTAGONIZING SIGNAL TRANSDUCTION IN DORSAL ROOT GANGLION CELLS
Use of antagonists to IL-31Ra and OSMRb are used to treat inflammation and pain by inhibiting, preventing, reducing, minimizing, limiting or minimizing...
2018/0044425 NOVEL ANTIBODIES AND USES THEREOF
The present invention provides an antibody or an antigen-binding fragment thereof with binding specificity for human interleukin-1 receptor accessory protein...
2018/0044424 CAR-EXPRESSING CELLS AGAINST MULTIPLE TUMOR ANTIGENS AND USES THEREOF
The invention provides compositions and methods for treating cancer by using immune effector cells (e.g., T cells, NK cells) engineered to conditionally...
2018/0044423 TREATMENT OF CANCER USING A CD33 CHIMERIC ANTIGEN RECEPTOR
The invention provides compositions and methods for treating diseases associated with expression of CD33. The invention also relates to chimeric antigen...
2018/0044422 TREATING SOLID TUMOR BY TARGETING DECTIN-1 SIGNALING
Compositions and methods for treating solid tumors such as pancreatic ductal adenocarcinoma (PDA) via interfering with the Dectin-1 signaling pathway, for...
2018/0044421 ANTI-CLL-1 ANTIBODIES AND IMMUNOCONJUGATES
The invention provides anti-CLL-1 antibodies and immunoconjugates and methods of using the same.
2018/0044420 ANTI-CLL-1 ANTIBODIES AND IMMUNOCONJUGATES
The invention provides anti-CLL-1 antibodies and immunoconjugates and methods of using the same.
2018/0044419 COMBINATION THERAPY WITH A HYALURONAN-DEGRADING ENZYME AND AN IMMUNE CHECKPOINT INHIBITOR
Provided are methods of treatments with combinations or compositions containing a soluble hyaluronidase, such as a polymer-modified hyaluronidase, and an...
2018/0044418 COMBINATION OF A PD-1 ANTAGONIST AND VORINOSTAT FOR TREATING CANCER
The present disclosure describes combination therapies comprising an antagonist of Programmed Death 1 receptor (PD-1) and suberoylanilide hydroxamic acid...
2018/0044417 Chimeric Antigen Receptor (CAR) Comprising a CD19-Binding Domain
There is provided a chimeric antigen receptor (CAR) comprising a CD19-binding domain which comprises a) a heavy chain variable region (VH) having...
2018/0044416 Polymeric Fc proteins and methods of screening to alter their functional characteristics
The invention relates to polymeric Fc proteins which bind to human Fc-receptors and methods of screening said polymeric Fc proteins to alter their functional...
2018/0044415 ANTI-DLL3 CHIMERIC ANTIGEN RECEPTORS AND METHODS OF USE
Provided herein are novel anti-DLL3 chimeric antigen receptors and methods of using the same to treat proliferative disorders.
2018/0044414 METHODS AND COMPOSITIONS FOR TREATMENT OF SKIN DISORDERS
The invention provides methods and compositions for the treatment of a skin disorder associated with detrimental TNF.alpha. activity, such as psoriasis. The...
2018/0044413 Use of MIP-1Beta inhibitors for improving angiogenesis to reduce tissue ischemia and rescue diabetic vascular...
The present invention relates to a use of MIP-1.beta. inhibitor for promoting angiogenesis in diabetes mellitus patients so as to improve tissue ischemia in...
2018/0044412 MODIFIED-IgG ANTIBODIES THAT BIND TRANSFORMING GROWTH FACTOR-BETA1 WITH HIGH AFFINITY, AVIDITY AND SPECIFICITY
A modified IgG antibody binds and neutralizes TGF.beta.1 selectively and with high affinity and avidity. The modified IgG antibody comprises four polypeptide...
2018/0044410 ANGIOPOIETIN-LIKE 4 ANTIBODIES AND METHODS OF USE
The present invention relates to monoclonal antibodies binding to human angiopoietin-like 4 protein (hereinafter, sometimes referred to as "ANGPTL4"), and...
2018/0044409 ANTIBODY-MEDIATED TRANSDUCTION OF HEAT SHOCK PROTEINS INTO LIVING CELLS
The invention provides for a fusion protein comprising a 3E10 Fv joined to a Hsp-70, Hsp-27, Hsp-90 or GRP-78 or portion thereof, and optionally, the 3E10 Fv...
2018/0044408 ANTIGENS ASSOCIATED WITH INFLAMMATORY BOWEL DISEASE
Specific binding members that bind the ED-A isoform of fibronectin for use in methods of treatment, diagnosis, detection and/or imaging of inflammatory bowel...
2018/0044407 GLYCOSYLATED IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS
The present invention relates to glycosylated immunoglobulin variable domains, and in particular to glycosylated immunoglobulin single variable domains (the...
2018/0044406 ANTI-GLUCOSAMINIDASE PASSIVE IMMUNIZATION FOR STAPHYLOCOCCUS AUREUS INFECTIONS
The present invention is directed to a monoclonal antibody that binds specifically to a Staphylococcus aureus glucosaminidase and inhibits in vivo growth of S....
2018/0044405 METHOD OF PRODUCING RECOMBINANT HIGH MOLECULAR WEIGHT vWF IN CELL CULTURE
Among other aspects, the present invention relates to cell culture conditions for producing high molecular weight vWF, in particular, highly multimericWF with...
2018/0044404 IMMUNOMODULATORY FUSION PROTEINS AND USES THEREOF
The present disclosure relates to immunomodulatory fusion proteins containing an extracellular binding domain and an intracellular signaling domain, wherein...
2018/0044403 INTEGRIN-TARGETING PROTEIN AND METHODS OF USE THEREOF
A non-toxic anti-angiogenesis protein that inhibits tumor growth and exhibits in vitro activity in induction of angiogenic endothelial cell apoptosis without...
2018/0044402 Fc FUSION HIGH AFFINITY IgE RECEPTOR a-CHAIN
Provided is an Fc fusion high affinity IgE receptor .alpha.-chain having excellent stability at low pH. An Fc fusion protein comprising: (i) a high affinity IgE...
2018/0044401 IMMUNOGLOBULIN G-BINDING PEPTIDE
The objective of the present invention is to provide a peptide of which both of binding forces to a Fc region and a Fab region are superior. In addition, the...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.